Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	EWEdwards Lifesciences	BSXBoston Scientific	IDXXIdexx Laboratories
Snapshot
Price	$89.23	$44.72	$523.53
Market cap	$54.34B	$67.09B	$44.00B
Valuation
P/E	46.8x	18.6x	37.7x
Forward P/E	66.9x	13.3x	30x
Growth
Revenue growth	13.8%	17.4%	13.1%
EPS growth	-73.2%	74.7%	25.6%
Profitability
Net margin	17.4%	17.3%	24.6%
ROE	10.6%	14.9%	70.9%
Balance sheet & cash
Debt / equity	0.06x	0.47x	0.53x
Free cash flow yield	2.9%	3.5%	1.9%
Dividend yield	—	—	—
Verdict
Investment rating	Neutral· 47	Favorable· 71	Favorable· 69

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	EWtoday $89	BSXtoday $45	IDXXtoday $524
2027	$68.26 – $100.12+12% CAGR	$58.60 – $85.95+92% CAGR	$493.13 – $723.25+38% CAGR
2028	$69.63 – $102.12+7% CAGR	$102.39 – $150.17+83% CAGR	$619.32 – $908.33+32% CAGR
2029	$71.02 – $104.16+5% CAGR	$178.89 – $262.37+80% CAGR	$777.80 – $1,140.77+30% CAGR
2030	$72.44 – $106.24+4% CAGR	$312.56 – $458.42+79% CAGR	$976.84 – $1,432.70+29% CAGR
2031	$73.89 – $108.37+4% CAGR	$546.11 – $800.95+78% CAGR	$1,226.81 – $1,799.32+28% CAGR
5-yr CAGR	-3.7% – 4.0%	65.0% – 78.1%	18.6% – 28.0%